Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Coelho, Lara; Cardoso, Sandra; Amancio, Rodrigo; Moreira, Ronaldo; Ribeiro, Sayonara; Coelho, Alessandra; Campos, Dayse; Veloso, Valdiléa; Grinsztejn, Beatriz; Luz, Paula
• Is Part Of: BMC infectious diseases. Volume 16:Issue 1(2016)
• Page Start: 1
• Page End: 9
• Publication Date: 2016-12
• Subjects: AIDS-related opportunistic infections -- HIV -- Acquired immunodeficiency syndrome -- Incidence -- Cohort study -- Cox proportional hazards regression models; Communicable diseases -- Periodicals; Sexually Transmitted Diseases -- Periodicals; 616.905
• DOI: 10.1186/s12879-016-1462-x
• Languages: English
• ISSNs: 1471-2334

Abstract

Abstract Background Opportunistic illnesses still account for a huge proportion of hospitalizations and deaths among HIV-infected patients in the post combination antiretroviral therapy (cART) era, particularly in middle- and low-income countries. The aim of this study was to assess predictors of the top four most incident opportunistic illnesses (tuberculosis, esophageal candidiasis, cerebral toxoplasmosis andPneumocystis jiroveci pneumonia) in an HIV clinical cohort from a middle-income country in the post cART era. Methods A total of 2835 HIV infected participants aged ≥ 18 years at enrollment were followed from January 2000 to December 2012 until the occurrence of their first opportunistic illness, death or end of study, whichever occurred first. Extended Cox proportional hazards regression models, stratified by use of cART, were fitted to assess predictors of opportunistic illness incidence during follow-up. Results The incidence rates of tuberculosis, esophageal candidiasis, cerebral toxoplasmosis andPneumocystis jiroveci pneumonia were 15.3, 8.6, 6.0, 4.8 per 1000 persons-year, respectively. Disease specific adjusted Cox models showed that presence of an opportunistic illness at enrollment significantly increased disease incidence while higher nadir CD4+ T lymphocyte count had a significant protective effect in patients not in use of cART. Duration of cART use also significantly reduced disease incidence. Conclusions Our findings show that, still in the post-cART era, prevention of opportunistic infections can be achieved by preventing immune deterioration by instituting early use of cART. Interventions focusing on early diagnosis and linkage to care in addition to the prompt initiation of cART are essential to reduce the incidence of opportunistic illnesses among HIV infected patients in post-cART era.